BRCA1 compound heterozygous mutations in exon 11 (c.4065-4068del–p.Asn1355Lysfs*10) and in intron 22 (c.5406 + 7A > G–p.Asp1778Glyfs*27) were reported in another patient, mother of a girl, that developed ovarian and breast cancers at 43 and 44 years, without any FA-like symptoms [51]. This evidence concerns the gene BRCA1 and breast cancer.